Search research articles
Contact Us
Filters
Showing results (541-550 of 792) with videos related to
Page
of 80
Sort By:
Clinical and Translational Allergy
|
April 10, 2019
The REal Life EVidence AssessmeNt Tool (RELEVANT): development of a novel quality assurance asset to rate observational comparative effectiveness research studies
Jonathan D Campbell, Robert Perry, Nikolaos G Papadopoulos, et al.
Cancer Management and Research
|
December 18, 2018
Impact of inflammatory markers on survival in patients with limited disease small-cell lung cancer undergoing chemoradiotherapy
Denise Bernhardt, Sophie Aufderstrasse, Laila König, et al.
Clinical Lung Cancer
|
August 9, 2014
Long-term and low-grade safety results of a phase III study (PARAMOUNT): maintenance pemetrexed plus best supportive care versus placebo plus best supportive care immediately after induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small-cell lung cancer
Jean-Louis Pujol, Luis Paz-Ares, Filippo de Marinis, et al.
Transplantation Direct
|
July 15, 2017
Sirolimus Increases T-Cell Abundance in the Sun Exposed Skin of Kidney Transplant Recipients
Michael Thomas Burke, Lauren C Sambira Nahum, Nicole M Isbel, et al.
Hepatobiliary Surgery and Nutrition
|
June 9, 2020
Radioembolization for neuroendocrine liver metastases is safe and effective prior to major hepatic resection
Florian Bösch, Harun Ilhan, Vanessa Pfahler, et al.
JTO Clinical and Research Reports
|
July 26, 2022
<b>Brief Report: A Blood-Based MicroRNA Complementary Diagnostic Predicts Immunotherapy Efficacy in Advanced-Sta</b> <b>ge NSCLC With High Programmed Death-Ligand 1 Express</b> <b>ion</b>
Timothy Rajakumar, Rastislav Horos, Paul Kittner, et al.
Cancers
|
December 7, 2018
Glycodelin as a Serum and Tissue Biomarker for Metastatic and Advanced NSCLC
Marc A Schneider, Thomas Muley, Rebecca Weber, et al.
Translational Lung Cancer Research
|
June 24, 2021
Earlier extracranial progression and shorter survival in ALK-rearranged lung cancer with positive liquid rebiopsies
Petros Christopoulos, Steffen Dietz, Arlou K Angeles, et al.
British Journal of Cancer
|
June 12, 2024
KRAS and TP53 co-mutation predicts benefit of immune checkpoint blockade in lung adenocarcinoma
Jan Budczies, Eva Romanovsky, Martina Kirchner, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
March 7, 2025
Low-coverage whole genome sequencing of cell-free DNA to predict and track immunotherapy response in advanced non-small cell lung cancer
Florian Janke, Mateo Gasser, Arlou K Angeles, et al.
Page
of 80
Search research articles
Search
Showing results (541-550 of 792) with videos related to
Sort By:
Page
of 80
Clinical and Translational Allergy
|
April 10, 2019
The REal Life EVidence AssessmeNt Tool (RELEVANT): development of a novel quality assurance asset to rate observational comparative effectiveness research studies
Jonathan D Campbell, Robert Perry, Nikolaos G Papadopoulos, et al.
Cancer Management and Research
|
December 18, 2018
Impact of inflammatory markers on survival in patients with limited disease small-cell lung cancer undergoing chemoradiotherapy
Denise Bernhardt, Sophie Aufderstrasse, Laila König, et al.
Clinical Lung Cancer
|
August 9, 2014
Long-term and low-grade safety results of a phase III study (PARAMOUNT): maintenance pemetrexed plus best supportive care versus placebo plus best supportive care immediately after induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small-cell lung cancer
Jean-Louis Pujol, Luis Paz-Ares, Filippo de Marinis, et al.
Transplantation Direct
|
July 15, 2017
Sirolimus Increases T-Cell Abundance in the Sun Exposed Skin of Kidney Transplant Recipients
Michael Thomas Burke, Lauren C Sambira Nahum, Nicole M Isbel, et al.
Hepatobiliary Surgery and Nutrition
|
June 9, 2020
Radioembolization for neuroendocrine liver metastases is safe and effective prior to major hepatic resection
Florian Bösch, Harun Ilhan, Vanessa Pfahler, et al.
JTO Clinical and Research Reports
|
July 26, 2022
<b>Brief Report: A Blood-Based MicroRNA Complementary Diagnostic Predicts Immunotherapy Efficacy in Advanced-Sta</b> <b>ge NSCLC With High Programmed Death-Ligand 1 Express</b> <b>ion</b>
Timothy Rajakumar, Rastislav Horos, Paul Kittner, et al.
Cancers
|
December 7, 2018
Glycodelin as a Serum and Tissue Biomarker for Metastatic and Advanced NSCLC
Marc A Schneider, Thomas Muley, Rebecca Weber, et al.
Translational Lung Cancer Research
|
June 24, 2021
Earlier extracranial progression and shorter survival in ALK-rearranged lung cancer with positive liquid rebiopsies
Petros Christopoulos, Steffen Dietz, Arlou K Angeles, et al.
British Journal of Cancer
|
June 12, 2024
KRAS and TP53 co-mutation predicts benefit of immune checkpoint blockade in lung adenocarcinoma
Jan Budczies, Eva Romanovsky, Martina Kirchner, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
March 7, 2025
Low-coverage whole genome sequencing of cell-free DNA to predict and track immunotherapy response in advanced non-small cell lung cancer
Florian Janke, Mateo Gasser, Arlou K Angeles, et al.
Page
of 80